Abstract The coronavirus disease 2019 (COVID-19) pandemic has stimulated tremendous
efforts to develop therapeutic strategies that target severe acute respiratory syndrome …

Abstract Background Coronavirus disease 2019 (COVID-19) continues to pose a significant
threat to public health worldwide. The purpose of this study was to review current evidence …

Background Multiple early reports of patients admitted to hospital with COVID-19 showed
that patients with chronic respiratory disease were significantly under-represented in these …

Persistent breathlessness> 28 days after acute COVID-19 infection has been identified as a
highly debilitating post-COVID symptom. However, the prevalence, risk factors, mechanisms …

Background The coronavirus disease 2019 (COVID-19) caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to plague the world. While …

The major challenges encountered by medical researchers in developing new drugs are
time consumption, increased cost, establishing a safety profile for the drugs, poor solubility …

Despite aggressive efforts on containment measures for the coronavirus disease 2019
(COVID-19) pandemic around the world, severe acute respiratory syndrome coronavirus 2 …

Since the beginning of the COVID-19 pandemic, large in silico screening studies and
numerous in vitro studies have assessed the antiviral activity of various drugs on SARS-CoV …

Statement of Retraction We, the Editors and Publisher of Expert Review of Anti-Infective
Therapy, have retracted the following article: Mahmoud El-Bendary, Sherief Abd-Elsalam …

Since the first reports from December 2019, COVID-19 caused an overwhelming global
pandemic that has affected 223 countries, seriously endangering public health and creating …